Atopic eczema

Related records

Broader conditions (11)

• Allergic disease
• Dermatitis
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Human disease
• Hypersensitivity reaction disease
• Immune system disorder
• Inflammatory disease
• Integumentary system disorder
• Skin disorder

Narrower conditions (8)

• 2-hydroxyethyl methacrylate sensitization
• Allergic contact dermatitis
• Allergic contact dermatitis of eyelid
• Allergic cutaneous vasculitis
• Allergic urticaria
• Non-histaminic angioedema
• Photoallergic dermatitis
• Toxicodendron dermatitis

Trials (1,502)

• 0.005% Sodium Hypochlorite Final Rinse Solution in Atopic Dermatitis
• 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis
• A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
• A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
• A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement
• A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis
• A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection
• A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
• A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
• A Clinical Study of HRS-8797 in Healthy Participants
• A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
• A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.
• A Clinical Study to Evaluate SM17 for Atopic Dermatitis
• A Clinical Study to Evaluate SM17 in Healthy Participants
• A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer
• A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis
• A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
• A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
• A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Approved drugs (21)

• Abrocitinib
• Cortisone acetate
• Crisaborole
• Desonide
• Dexamethasone
• Dexamethasone sodium phosphate
• Doxepin hydrochloride
• Dupilumab
• Fluocinolone acetonide
• Fluticasone propionate
• Hydrocortisone
• Hydrocortisone butyrate
• Ipratropium bromide
• Lebrikizumab
• Methylprednisolone
• Pimecrolimus
• Prednisolone
• Prednisone
• Promethazine hydrochloride
• Tacrolimus

Drugs in development (145)

• 4-imidazolecarboxylic acid Phase 2
• Acloproxalap Phase 2
• Adriforant Phase 2
• Afimkibart Phase 2
• Amlitelimab Phase 3
• Ammonium trichlorotellurate Phase 2
• Antroquinonol Phase 2
• Apremilast Phase 2
• Astegolimab Phase 2
• Atuzabrutinib Phase 2
• AWD-12-281 Phase 2
• Baricitinib Phase 3
• Bempikibart Phase 2
• Benralizumab Phase 2
• Bergapten Phase 3
• Bermekimab Phase 2
• Betamethasone Phase 2
• Betamethasone dipropionate Phase 1
• Betamethasone valerate Phase 3
• Bimosiamose Phase 2

Other linked drugs (18)

• Aspirin
• Bilastine
• Cortisone
• Cromolyn sodium
• Desloratadine
• Dimethindene
• Epinastine hydrochloride
• Fexofenadine hydrochloride
• Levocetirizine dihydrochloride
• Montelukast
• Olopatadine hydrochloride
• Ovatodiolide
• Palmidrol
• Pioglitazone
• Piperazine
• REGN-846
• Resomelagon acetate
• Rituximab